Dow Up 0.26% Nasdaq Down 1.07%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
5.81 0.16(2.68%) Sep 15, 4:00PM EDT
Prev Close:5.97
Open:5.95
Bid:5.64 x 100
Ask:6.00 x 100
1y Target Est:8.72
Beta:1.51
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.75 - 5.99
52wk Range:2.15 - 21.55
Volume:7,143,024
Avg Vol (3m):7,294,550
Market Cap:1.09B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIADown 2.68%1.09B
NVS228.50B
PFE189.72B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.15
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback